AZ St-Jan Brugge - Laboratoriumgeneeskunde |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
dr. Helena Devos/Friedel Nollet, Ph.D. |
|
|
IPG Gosselies |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
P. Vannuffel
C. De Rop |
|
|
UZ Gent |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Barbara Denys,
Karl Vandepoele |
|
|
UZA Mol. Diagn. |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
K. Vermeulen,
M. Le Mercier,
M-B Maes |
|
|
UZ Brussel - Molecular Hematology |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Marleen Bakkus/Barbara Depreter |
|
|
CHU Liège - Hemato |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Dr Frédéric Lambert |
|
|
Jessa Hospital |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Dr. Brigitte Maes, Ellen Geerdens |
|
|
LHUB-ULB |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Pierre Heimann/Laurent Dewispelaere/Pascale Cochaux/Hakim El Housni |
|
|
GZA St-Augustinus |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Philippe Van Lint |
|
|
OLVZ Aalst |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Anne Vankeerberghen |
|
|
AZ St-Lucas Gent |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
DR H. Louagie / Koen Jacobs |
|
|
UZ Leuven MolPLUZ |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
N. Boeckx, L. Michaux |
|
|
AZ Delta |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Elisabeth Moreau/Elke Boone |
|
|
ZNA Middelheim |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Pieter De Schouwer |
|
|
Labo Cliniques Sud Luxembourg |
BCR-ABL1 p210 (e13a2/e14a2) quantitative analysis
|
Nicolas Hougardy |
|
|
primers from EAC consortium, Gabert et al. Leukemia (2003)
Version date: 04/11/2017
Accredited: